CVI Holdings’s Lexaria Bioscience Warrant LEXXW Stock Holding History

CVI Holdings’s Portfolio LEXXW Stock Details LEXXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$33.6K	Hold	41,651	–	–	0.03%	62
2024 Q1	$62.5K	Hold	41,651	–	–	0.06%	40
2023 Q4	$18.7K	Sell	41,651 -349	-0.8%	-$116	0.04%	69
2023 Q3	$8.82K	Hold	42,000	–	–	0.02%	122
2023 Q2	$9.24K	Hold	42,000	–	–	0.01%	165
2023 Q1	$24.2K	Hold	42,000	–	–	0.01%	201
2022 Q4	$16.8K	Hold	42,000	–	–	﹤0.01%	352
2022 Q3	$25K	Hold	42,000	–	–	﹤0.01%	523
2022 Q2	$29K	Sell	42,000 -3,000	-7%	-$2.63K	﹤0.01%	578
2022 Q1	$40K	Hold	45,000	–	–	﹤0.01%	661
2021 Q4	$68K	Hold	45,000	–	–	﹤0.01%	719
2021 Q3	$95K	Hold	45,000	–	–	0.01%	645
2021 Q2	$113K	Hold	45,000	–	–	0.01%	581
2021 Q1	$108K	Buy	+45,000	New	+$98.7K	0.01%	477

Other funds holding LEXXW

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

CVI Holdings's LEXXW Position: Q2 2024 in Review

CVI Holdings held its Lexaria Bioscience Warrant (LEXXW) position steady in Q2 2024 at 41,651 shares worth $33.6K. The position accounts for 0.03% of the portfolio, ranked #62.

CVI Holdings first reported a position in LEXXW in Q1 2021 and has held it in 14 quarters since. The position peaked at $113K in Q2 2021. 3 funds tracked by Wall St. Rank hold LEXXW as of Q2 2024.

CVI Holdings held 41,651 shares of Lexaria Bioscience Warrant worth $33.6K as of Q2 2024.
CVI Holdings left its Lexaria Bioscience Warrant share count unchanged in Q2 2024.
Lexaria Bioscience Warrant made up 0.03% of CVI Holdings's portfolio in Q2 2024, its #62 holding.
CVI Holdings first reported a position in Lexaria Bioscience Warrant in Q1 2021 and has held it in 14 quarters since.
CVI Holdings's Lexaria Bioscience Warrant position peaked at $113K in Q2 2021.
3 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.